DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alkermes plc (ALKS)
« Back to company indexALKS Chatter Timeline
Stock Ticker for ALKS
Most Active Tweeters for ALKS
| User | Tweets |
|---|---|
| @reurope_stock | 12 |
| @whatsonthorold2 | 12 |
| @bulletin_en | 9 |
| @mmahotstuff1 | 9 |
| @thefinreviewer | 9 |
Recent Tweets for ALKS
 |
@1MinuteStock Wondering about risks of $ALKS? The 63-day volatility is 19.05% https://t.co/cQn3ldIe1K April 19th 2019, 3:04am |
|
@1MinuteStock Wondering about risks of $ALKS? The 21-day volatility is 11.91% https://t.co/cQn3ldIe1K April 19th 2019, 2:04am |
 |
@Allstocknews $ALKS Alkermes to Host Conference Call to Discuss First Quarter 2019 Financial Results From our Stock News Alerts App April 18th 2019, 4:04pm |
 |
@mmahotstuff1 Institutional Investors Are Selling Alkermes PLC $ALKS https://t.co/IzSH1UL5o5 April 18th 2019, 2:04pm |
 |
@reurope_stock Alkermes PLC $ALKS: Institutional Investors Aren't Crazy About It https://t.co/MnhAfNxK47 April 18th 2019, 2:04pm |
|
@mmahotstuff1 Alkermes Inc $ALKS Institutional Investors Sentiment Index Dropped in Q4 2018 https://t.co/pzarCBn1bF April 18th 2019, 2:04pm |
 |
@BuyOnStrength $ALKS out. https://t.co/GsNmoAuqPr April 18th 2019, 12:04am |
 |
@thefinreviewer Ascendis Pharma A/S $ALKS https://t.co/pqHTWj4tmi April 17th 2019, 7:04pm |
 |
@GoGoBio RT @BlogYomi: Miles Capital Has Decreased Holding in Pfizer $PFE as Share Value Declined; Alkermes Com $ALKS Shareholder Bogle Investment M… April 17th 2019, 4:04pm |
 |
@SwingTradeBot Fell Below 50 DMA today: $ALKS $GHII ... https://t.co/j2lcQOTpfA April 17th 2019, 3:04pm |
|
@thefinreviewer Meditor Group LTD Has Trimmed Alkermes Plc $ALKS Position by $4.01 Million as Share Value Declined; Annaly Cap Mgmt… https://t.co/OfvZxlKdva April 17th 2019, 11:04am |
 |
@BlogYomi Miles Capital Has Decreased Holding in Pfizer $PFE as Share Value Declined; Alkermes Com $ALKS Shareholder Bogle In… https://t.co/xzK81jb0GV April 17th 2019, 8:04am |
 |
@bulletin_en As of April, 25 Alkermes plc $ALKS EPS Estimated At $-0.38 https://t.co/9dr5F9lyu7 April 16th 2019, 11:04am |
|
@BlogYomi Realm Therapeutics Plc $ALKS https://t.co/jPdtgwYjyk April 16th 2019, 11:04am |
|
@mmahotstuff1 What's Propelling Alkermes plc $ALKS to Increase So Much? https://t.co/7KCWLsqOxP April 16th 2019, 11:04am |
|
@BlogYomi Alkermes Com $ALKS Position Has Increased by Bogle Investment Management Lp; Cintas $CTAS Stock Rose While Contravi… https://t.co/a6HMnVVzeX April 16th 2019, 8:04am |
|
@mmahotstuff1 As Alkermes Plc $ALKS Valuation Declined, Meditor Group LTD Has Cut Holding by $4.01 Million https://t.co/p9oXnICPCJ April 16th 2019, 6:04am |
 |
@whatsonthorold2 Meditor Group LTD Lowered Its Alkermes Plc $ALKS Stake by $4.01 Million https://t.co/P2gF0vydYm April 16th 2019, 6:04am |
 |
@bibeypost_stock Meditor Group LTD Decreased Its Alkermes Plc $ALKS Position by $4.01 Million https://t.co/1f8trljlWQ April 16th 2019, 6:04am |
|
@reurope_stock Meditor Group LTD Has Trimmed Stake in Alkermes Plc $ALKS by $4.01 Million as Stock Declined https://t.co/9M6Q2UuxEG April 16th 2019, 6:04am |
|
@thefinreviewer Franklin Resources Has Boosted Its Alkermes Plc $ALKS Position; S&W Seed Co Has 0.92 Sentiment https://t.co/fyl0iKhkJ4 April 15th 2019, 4:04pm |
|
@bulletin_en As of April, 25 The EPS for Alkermes plc $ALKS Expected At $-0.38 https://t.co/4xTnMImgTt April 15th 2019, 10:04am |
|
@bibeypost_stock Alkermes plc $ALKS EPS Estimated At $-0.38 https://t.co/E35wjw8pKu April 15th 2019, 10:04am |
|
@whatsonthorold2 Can analysts adopt a bullish outlook for Alkermes plc $ALKS? https://t.co/9jKjEfdhSG April 15th 2019, 8:04am |
|
@BlogYomi Alkermes Plc $ALKS Shareholder Proshare Advisors Has Cut Its Holding as Market Value Declined; As Ani Pharmaceutica… https://t.co/fyrmExF66S April 15th 2019, 8:04am |
|
@bulletin_en Alkermes Plc - Ordinary Shares $ALKS Sellers Strengthened By 7.77% Their Shorts As Of Apr 15, 2019 https://t.co/SG1aDARl0Z April 15th 2019, 6:04am |
 |
@ZolmaxNews JPMorgan Chase & Co. Reaffirms Buy Rating for Alkermes $ALKS https://t.co/C60GYIpU7T April 14th 2019, 11:04am |
 |
@dailypoliticaln JPMorgan Chase & Co. Reaffirms Buy Rating for Alkermes $ALKS https://t.co/oPYtUrYXUM April 14th 2019, 11:04am |
|
@bibeypost_stock EPS for Alkermes plc $ALKS Expected At $-0.38 https://t.co/76PKQilKzF April 13th 2019, 4:04pm |
|
@bulletin_en Meditor Group LTD Decreased Stake in Alkermes Plc $ALKS https://t.co/9zrnu8sUex April 13th 2019, 6:04am |
|
@mmahotstuff1 As Alkermes Plc $ALKS Market Valuation Declined, Meditor Group LTD Has Lowered by $4.01 Million Its Stake https://t.co/R4UWTKOYwR April 13th 2019, 6:04am |
|
@whatsonthorold2 Meditor Group LTD Decreased Stake in Alkermes Plc $ALKS by $4.01 Million as Market Valuation Declined https://t.co/N6YKbVA437 April 13th 2019, 6:04am |
|
@reurope_stock As Alkermes Plc $ALKS Share Value Declined, Meditor Group LTD Has Decreased Its Position https://t.co/dcNCuLd0WT April 13th 2019, 6:04am |
 |
@StockflareUS $ALKS: Alkermes Plc is cheaper today at 95x earnings than it was a week ago at 104x earnings. (https://t.co/PRw0DWuGc5) April 13th 2019, 5:04am |
|
@BlogYomi Dova Pharmaceuticals Inc. $ALKS Comparing side by side https://t.co/bbaApD4eDX April 12th 2019, 9:04pm |
|
@bulletin_en Comparing of Editas Medicine Inc. $ALKS https://t.co/cqvAjwDYUH April 12th 2019, 8:04pm |
 |
@Kevin_dreaming RT @theflynews: Alkermes' ALKS-3831 ph3 data saw negligible relative benefit, says Piper Jaffray $ALKS https://t.co/R9TLe2USYE April 12th 2019, 7:04pm |
 |
@sleekoptions #Update(8) $ALKS May-17 35 Calls C Up +35%. since alerted on: Mar 15. Peak 119% View Details:… https://t.co/pNKA9TLbjB April 12th 2019, 4:04pm |
 |
@theflynews Alkermes' ALKS-3831 ph3 data saw negligible relative benefit, says Piper Jaffray $ALKS https://t.co/R9TLe2USYE April 12th 2019, 4:04pm |
|
@mmahotstuff1 Analysts See $-0.38 EPS for Alkermes plc $ALKS https://t.co/VJxXPcsELR April 12th 2019, 3:04pm |
|
@whatsonthorold2 Alkermes plc $ALKS Analysts See $-0.38 EPS https://t.co/a7zS82evi3 April 12th 2019, 3:04pm |
|
@reurope_stock Alkermes plc $ALKS Analysts See $-0.38 EPS https://t.co/Qo1NOviM7M April 12th 2019, 3:04pm |
|
@mmahotstuff1 It Seems Alkermes plc $ALKS Will Go Down. Have Another Big Decline https://t.co/hh5CeN1iXj April 12th 2019, 2:04pm |
|
@whatsonthorold2 Alkermes plc $ALKS Declines A lot Today, Is Now One of The Worst Performer https://t.co/LaDz9BNOc9 April 12th 2019, 2:04pm |
|
@bibeypost_stock Is Selling Alkermes plc $ALKS Here a Winning Strategy? https://t.co/uHmHgNsLQD April 12th 2019, 2:04pm |
|
@reurope_stock Today Alkermes plc $ALKS Stock Crashes https://t.co/2wof9NCuar April 12th 2019, 2:04pm |
|
@bulletin_en $-0.38 EPS Expected for Alkermes plc $ALKS on April, 25 https://t.co/vP5CmtGXCu April 12th 2019, 11:04am |
 |
@stocknewstimes Alkermes $ALKS Rating Reiterated by JPMorgan Chase & Co. https://t.co/Y9hGT31vK1 April 12th 2019, 11:04am |
 |
@susanfoofoo $ALKS m:Alkermes says ALKS 3831 showed 'statistically significant improvement' in study https://t.co/GwLcpmhH31 April 12th 2019, 9:04am |
|
@thefinreviewer Meditor Group LTD Position in Alkermes Plc $ALKS Has Trimmed as Stock Value Declined; Eubel Brady & Suttman Asset M… https://t.co/XsE09O75oM April 12th 2019, 5:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.